| abstract |
The present invention comprises compounds of the Formula I. wherein: R1, R2, R3, R4, R5, R6, R7, R8 and R9 are defined in the specification. The invention further comprises a medicament for treating or improving a syndrome, a disorder or a disease d, wherein the syndrome, the disorder or the disease is rheumatoid arthritis or psoriasis. The invention further comprises a medicament for modulating the activity of RORyt in a mammal by administering a therapeutically effective amount of at least one compound of claim 1. |